Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cellsShaowei Qiu, Ravi Bhatia, Victor Darley‐Usmar et al.|Blood|2023Cited by 39
Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signalingNicholas R. Anderson, Ravi Bhatia, Vipul Sheth et al.|Leukemia|2022Cited by 31
Autophagy inhibition impairs leukemia stem cell function in FLT3-ITD AML but has antagonistic interactions with tyrosine kinase inhibitionShaowei Qiu, Ravi Bhatia, Harish Kumar et al.|Leukemia|2022Cited by 15
Low c-Kit expression identifies primitive, therapy-resistant CML stem cellsMansi Shah, Ravi Bhatia, Harish Kumar et al.|JCI Insight|2022Cited by 11
CXCL12 Knock-out Enhances Leukemia Stem Cell Response to Combination Chemotherapy Plus Tyrosine Kinase Inhibition in Flt3-ITD Acute Myeloid LeukemiaNick R Anderson, Ravi Bhatia, Hui Li et al.|Blood|2020Cited by 2